![Macfarlane Group Plc](/common/images/company/L_MACF.png)
SEATTLE, July 22, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced that the 12-patient 80mg pharmacokinetic (PK) run-in cohort of the...
SEATTLE, July 02, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), today announced the appointment of Heather Rees as the Company’s new Chief...
SEATTLE, June 28, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced protocol changes in the previously initiated study to evaluate...
SEATTLE, June 17, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), today announced its expected upcoming inclusion in the Russell 3000® Index...
SEATTLE, June 05, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), today announced that the Company will present at the Sidoti Small-Cap Investor...
SEATTLE, May 28, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), today announced support for a new Phase 2 study designed to validate an...
SEATTLE, May 15, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced that the last patient in the Company’s Karisma-Endoxifen clinical...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -3 | -2.34375 | 128 | 128 | 125 | 49697 | 125.83774201 | DE |
4 | 6 | 5.04201680672 | 119 | 131 | 115 | 139643 | 123.42722002 | DE |
12 | -3 | -2.34375 | 128 | 131 | 115 | 232847 | 123.05358756 | DE |
26 | 4 | 3.30578512397 | 121 | 147 | 115 | 312835 | 130.45763797 | DE |
52 | 13.5 | 12.1076233184 | 111.5 | 147 | 98.6 | 258925 | 123.7398895 | DE |
156 | 11 | 9.64912280702 | 114 | 147 | 85.2 | 218638 | 119.6870567 | DE |
260 | 30 | 31.5789473684 | 95 | 147 | 61 | 194729 | 111.26153858 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.